Biological E is predicted to produce 30 crore doses, Zydus Cadila 5 crore, Serum Institute of India 20 crore doses of Novavax, and Bharat Biotech 10 crore doses of its nasal vaccine, whereas Gennova will make available 6 crore doses and Sputnik V 15.6 crore doses.
